BEAR : ‘Bioactive compounds Enrichment by Assay Repositioning’ virtual drug screening

Item Number: 608
Industry: Research, Therapeutic
Category: Drug Discovery / Screening
Development Stage: Research
Organisation Type: University
Country: South Korea
Patent: Korea, USA, Europe
Business Opportunity: Out-Licensing, Collaboration R&D


BEAR presents several advantages over conventional VS methods, in that it depends on the bioactivity data rather than structural information, it facilitates scaffold hopping, and can easily be scaled to screen for thousands of targets. 

Features & Contact

Sign in and you'll be able to send enquiries about this item, view full details and save it